Clicky

Health

Relief Reports US Collab. Partner Announces Submission to FDA seeking EUA for Aviptadil for Pts at Immediate Risk of Death from COVID-19 Despite Treatment w/Remdesivir, Other Approved Therapies

440 386 Merci

GENEVA, SWITZERLAND / ACCESSWIRE / January 6, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (“ Relief “), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need,…

Relief Reports U.S. Collab. Partner Announces Filing Breakthrough Therapy Request for Aviptadil in Pts at Immediate Risk of Death from COVID-19 Despite Treatment w/Remdesivir, Other Approved Therapies

440 386 Merci

GENEVA, SWITZERLAND / ACCESSWIRE / December 30, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (“Relief“), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today that the…

Empower Clinics Kai Medical Laboratory Secures COVID-19 Testing Contract For Large Gaming Event In Las Vegas

270 50 Todd

Kai Medical Laboratory to Provide Over 6,000 Rapid Antigen and PCR COVID-19 Tests VANCOUVER, BC / ACCESSWIRE / December 13, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company –…

Ainos Announces Strategic Relationship with InnoPharmax to Jointly Develop Combined Oral Therapy for Coronavirus Infection

150 150 Robert

SAN DIEGO, CA / ACCESSWIRE / December 7, 2021 / Ainos, Inc. (“we”, “our”, or the “company”), (OTC PINK:AIMD), a diversified healthcare company engaged in the discovery and development of pharmaceutical, medical devices and biotech…

Relief Reports U.S. Collaboration Partner Identifies Significantly Higher Likelihood of Surviving & Recovering from Critical COVID-19 in Aviptadil Treated Patients Previously Administered Remdesivir

440 386 Merci

GENEVA, SWITZERLAND / ACCESSWIRE / November 29, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTC PINK:RLFTY) (“Relief“), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today that…

Enzolytics Announces Progress As It Recognizes World AIDS Day

392 163 Jane

COLLEGE STATION, TX / ACCESSWIRE / December 2, 2021 / Enzolytics wishes to recognize and acknowledge World AIDS Day – a day to call attention to the continued need for a more effective treatment for…

Hayes’ Healthcare Audit and Revenue Integrity Analysis finds COVID-19 Claims and Bundling Errors Driving Denials

198 71 Todd

WELLESLEY, MA / ACCESSWIRE / October 28, 2021 / Bundling errors continue to wreak havoc on hospital bottom lines in 2021, causing 34% of inpatient charge denials with an average value of $5,300 each. That’s…

AXON Neuroscience Presented Results from its Phase II Clinical Trial Showing Multifold Therapeutic Effect of its Vaccine-Induced Antibodies at Eurotau2021

1929 1535 Jane

AXON presented results from its Phase II Clinical Study for AADvac1, vaccine against Alzheimer’s presented at Eurotau2021AXON demonstrated that vaccination-induced antibodies can stop the interaction and spreading of pathological tau species and protect the brain…

MorphoSys AG: First Patient Dosed in Phase 2 IGNAZ Study of Felzartamab in Patients with Immunoglobulin A Nephropathy

295 80 Merci

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / October 20, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that the first patient has been dosed in the Phase 2 IGNAZ clinical trial evaluating felzartamab for patients with Immunoglobulin A…

denTEL Directory Enables Dental Care Providers To Connect With Right Patients

150 150 Tori

NEW YORK, NY / ACCESSWIRE / October 12, 2021 / denTEL, a specialized oral health directory was introduced with an aim for patients to find a dentist near their location. It even helps oral health…